Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-134-4 | CAS number: 78-70-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- October 5, 1993 - November 16, 1993
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- Test was conducted comparable to OECD Test Guideline No. 476, under GLP Standards, and QA.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 994
- Report date:
- 1994
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- mammalian cell gene mutation assay
Test material
- Reference substance name:
- Linalool
- EC Number:
- 201-134-4
- EC Name:
- Linalool
- Cas Number:
- 78-70-6
- Molecular formula:
- C10H18O
- IUPAC Name:
- 3,7-dimethylocta-1,6-dien-3-ol
- Details on test material:
- - Name of test material (as cited in study report): B276
- Physical state: liquid
- Lot/batch No.: confidential
Constituent 1
Method
- Target gene:
- Thymidine kinase (TK) gene
Species / strain
- Species / strain / cell type:
- mouse lymphoma L5178Y cells
- Details on mammalian cell type (if applicable):
- - Type and identity of media: culture medium: RPMT 1640 medium; treatment medium: Fischer's medium
- Properly maintained: Yes
- Periodically checked for Mycoplasma contamination: Yes
- Periodically checked for karyotype stability: Yes
- Periodically "cleansed" against high spontaneous background: Yes - Additional strain / cell type characteristics:
- not applicable
- Metabolic activation:
- with and without
- Metabolic activation system:
- Rat liver S9 (from Aroclor 1254 treated male Sprague Dawley rats)
- Test concentrations with justification for top dose:
- Without metabolic activation: 1) 12.5, 25, 50, 100, 200, 250 µg/ml; 2) 25, 50, 100, 145, 200, 224, 274 µg/ml
With metabolic activation: 1) 12.5, 25, 50, 100, 200, 250 µg/ml; 2) 25, 50, 100, 145, 200, 224 µg/ml - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
Controls
- Untreated negative controls:
- yes
- Remarks:
- media (unexposed) (± S9 mix)
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO (± S9 mix)
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: S9: Methyl methanesulfonate; +S9: 3-Methylcholanthrene
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: In medium
DURATION
- Exposure duration: 4 hours
- Expression time (cells in growth medium): 2 days
- Fixation time (start of exposure up to fixation or harvest of cells): 10 - 14 days
SELECTION AGENT (mutation assays): Trifluorothymidine (TFT) ( Thymidine analog)
NUMBER OF REPLICATIONS: One culture per dose level; 3 disks per culture
NUMBER OF CELLS EVALUATED: 10*6
DETERMINATION OF CYTOTOXICITY
- Method: relative total growth: Reduction in cell growth relative to the concurrent negative control cultures - Evaluation criteria:
- The minimum criterion considered necessary to demonstrate mutagenicity for any given treatment is a mutant frequency that is equal or greater 2 times the concurrent background mutant frequency. The background mutant frequency is defined as the average mutant frequency of the negative control cultures.
To evaluate a test material as a mutagen the following test results must be obtained for either activation or nonactivation conditions:
- A dose-related or toxicity-related increase in mutant frequency should be observed.
- A mutagenic response in one mutation assay should be confirmed in the second mutation assay.
- If the mutant frequency obtained for a single dose at or near the highest testable toxicity is about four times the concurrent background mutant frequency or greater, the trial is considered mutagenic. However, for the test article to be evaluated as positive, the increase must be repeatable in the second trial.
- For some test materials, the correlation between toxicity and applied concentration is poor. Therefore either parameter, applied concentrations or toxicity (percent relative growth), is used to establish whether the increase in mutant frequency is related to an increase in effective treatment.
A test article is evaluated as nonmutagenic in a single assay only if the minimum increase in mutant frequency is not observed for a range of applied concentrations that extends to toxicity causing ten to twenty percent relative growth or in the case of relatively nontoxic materials, a range of applied concentrations extending to the maximum of 5 mg/ml. - Statistics:
- No data
Results and discussion
Test results
- Key result
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- >=125 µg/mL based on the range finding experiment; concentations >=200 µg/mL were toxic in the main experiment in the presence and absence of metabolic activation.
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
-
RANGE-FINDING/SCREENING STUDIES: The test material was tested in the preliminary rangefinding cytotoxicity assay both with and without S9 metabolic activation. The cytotoxicity assays were initiated with treatments from 1.95 µg/mL to 998 µg/mL. With and without metabolic activation, total cellkilling was observed at 499 µg/mL. The 250 µg/mL treatments were highly toxic under both testing conditions (10.8 % and 11.8 % relative survivals). Lower concentrations induced moderate to no toxicity. These results were used to select dose levels for the mutation assays.
COMPARISON WITH HISTORICAL CONTROL DATA: Yes. The average vehicle control mutant frequency was in the acceptable range in all trials. The positive control treatments induced mutant frequencies that were greatly in excess of the background and met assay acceptance criteria.
ADDITIONAL INFORMATION ON CYTOTOXICITY:
- S9 Mutation assays: in Trial 1 the six analyzed treatments (12.5 to 250 µg/mL) induced moderate to no toxicity (236.8% to 30.2% relative growth).
In Trial 2 the six analyzed treatments (25.0 to 224 µg/mL) induced relative growths that ranged from 80.2% to 23.4%; > 274 µg/mL was lethal.
+S9 Mutation assays: in Trial 1 the six analyzed treatments (12.5 to 250 µg/mL) induced a wide range of toxicities (134.9% to 10.8% relative growths). In Trial 2 the five analyzed treatments (25.0 to 200 µg/mL) induced a wide range of toxicities (143.5% to 17.6% relative growth); >= 224 µg/mL was lethal.
Any other information on results incl. tables
Not relevant
Applicant's summary and conclusion
- Conclusions:
- Negative with and without metabolic activation
Linalool was not mutagenic with and without metabolic activation in the mouse lymphoma forward mutation assay under the conditions of testing. It was concluded that linalool does not need to be classified as mutagenic according to Annex I of Regulation (EC) No. 1272/2008. - Executive summary:
The objective of this in vitro assay was to evaluate the ability of Linalool to induce forward mutations at the thymidine kinase (TK) locus in the mouse lymphoma L5178Y cell line, using Trifluorothymidine (TFT) as selection agent. The test material was soluble in Dimethylsulfoxide (DMSO) at approximately 100 mg/mL. In the preliminary cytotoxicity assays, cells were exposed to the test material for four hours in the presence and absence of rat liver S9 metabolic activation. The test material produced dose-related toxicity, starting at 200 µg/mL with and without activation. The test material was soluble in mediums up to approximately 200 µg/mL and the pH was maintained at or above 7.0.
Under non activation conditions, eight treatments from 12.5 µg/mL to 500 µg/mL were initiated in the first trial and the 350 µg/mL and 500 µg/mL doses were terminated because of excessive toxicity. The remaining six treatments were nontoxic to moderately toxic. In the next nonactivation assay, ten treatments from 25.0 µg/mL to 399 µg/mL were initiated and seven treatments from 25.0 µg/mL to 274 µg/mL were cloned for mutant analysis. One treatment induced less than 10 % relative growth and the remaining six treatments induced moderate to high toxicities. Relative growths ranged from 80.2% to 23.4%. No acceptable treatment in either trial induced a mutant frequency that exceeded the minimum criterion for a positive response. The test material was considered negative without activation in this assay.
In the presence of metabolic activation, small increases at 200 and 250 µg/mL were observed in Trial I that just exceeded the minimum criterion for a positive response, but the increases in the mutant frequencies were not observed in Trial 2. In the first activation assay, eight treatments from 12.5 µg/mL to 500 µg/mL were initiated and six of the eight treatments were cloned for mutant analysis. A wide range of toxic actions was induced. The increases occurred at insoluble dose levels. In addition, both positive treatments were very toxic the day after treatment and were not split back. In the second activation assay, ten treatments from 25.0 µg/mL to 399 µg/mL were initiated and treatments above 250 µg/mL were terminated because of excessive toxicity. One treatment at 224 µg/mL had a percent relative growth that was less than 10 %. The remaining six treatments induced a good range of toxic action. None of the acceptable treatments induced a mutant frequency that exceeded the minimum criterion for a positive response. Because of the lack of a repeatable response, Linalool was considered negative with activation in this assay.
Linalool was evaluated as negative with and without metabolic activation in the L5178Y mouse lymphoma forward mutation assay under the conditions used in this assay. It was concluded that linalool does not need to be classified as mutagenic according to Annex I of Regulation (EC) No. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.